Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Esophageal Neoplasms × Azacitidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 189 Myelodysplastic Syndromes 78 Leukemia 40 Leukemia, Myelomonocytic, Chronic 32 Recurrence 15 Myeloproliferative Disorders 12 Neoplasm, Residual 10 Lymphoma, T-Cell, Peripheral 10 Leukemia, Biphenotypic, Acute 10 Lymphoma 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Myelodysplastic-Myeloproliferative Diseases 7 Anemia, Refractory, with Excess of Blasts 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Non-Hodgkin 6 Primary Myelofibrosis 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hodgkin Disease 5 Hematologic Neoplasms 5 Congenital Abnormalities 5 Multiple Myeloma 4 Lymphoma, T-Cell 4 Lymphoma, Follicular 4 Breast Neoplasms 4 Polycythemia Vera 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Lymphoma, Extranodal NK-T-Cell 3

Interventions

Cisplatin 97 Radiotherapy 91 Fluorouracil 81 Paclitaxel 70 Oxaliplatin 57 Docetaxel 54 Carboplatin 47 Irinotecan 39 Esophagectomy 38 Leucovorin 37 Surgical Procedures, Operative 34 Capecitabine 34 Radiation 31 Drug Therapy 25 Neoadjuvant Therapy 21 Cetuximab 17 Chemoradiotherapy 16 pembrolizumab 15 S 1 (combination) 15 Magnetic Resonance Spectroscopy 15 Bevacizumab 15 camrelizumab 14 Nivolumab 14 Blood Specimen Collection 13 Surveys and Questionnaires 12 Radiotherapy, Intensity-Modulated 11 Trastuzumab 10 Immunotherapy 10 Epirubicin 10 Endoscopic Mucosal Resection 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01386346 2018-12-12

VEOX

Weill Medical College of Cornell University

Phase 1 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡